Materials and Reagents

Cell culture flask
30 gauge insulin syringe (BD, catalog number: 328431 ) Nr4a1-GFP (The Jackson Laboratory, catalog number: 018974 ), CX3CR1-GFP (The Jackson Laboratory, catalog number: 005582 ) or other fluorescent reporter mouse for visualizing immune cells.
½ micro-cover glass (12 mm diameter) (Electron Microscope Sciences, catalog number: 72230-01 )
PE-90 tubing (BD, Intramedic^TM, catalog number: 427420 )
Mice
Lewis lung carcinoma cells expressing red fluorescent protein (LLC-RFP) or other fluorescent-tagged tumor cell line (AntiCancer.com)
TrypLE^TM Express enzyme(Thermo Fisher Scientific, Gibco^TM, catalog number: 12604013 )
Dulbecco's phosphate-buffered saline (DPBS) (GE Healthcare, Hyclone^TM, catalog number: SH30038.02 )
Ketamine hydrochloride
Xylazine hydrochloride
Vetbond glue (3M, catalog number: 1469SB )
Oxygen
Ethanol
Dow Corning^® high vacuum grease (Sigma-Aldrich, catalog number: Z273554 )

Equipment

Centrifuge
Mechanical mouse ventilator (Harvard Apparatus, model: 845 )
Fine dissecting tweezers and scissors (Fine Scientific Tools)
Suction ring for imaging (Mekilect, catalog number: Suction Ring )
Vacuum line with pressure regulator and pressure gauge
Upright confocal or 2photon microscope with resonance scanner (we use a Leica SP5), heated stage and long distance 20-25x water immersion objective suitable for live imaging.

Software

Imaris software (version 7.1.1 x 64) (Bitplane, http://www.bitplane.com/download/manuals/ReferenceManual6_1_0.pdf)
Prism software (GraphPad Software)

Procedure

Tumor injection
1. Collect LLC-RFP tumor cells at about 70-80% confluency grown in a cell culture flask. Wash with DPBS two times and then gently trypsinize cells for approximately 3-5 min. We find that the greatest amount of reproducibility with tumors that are 70-80% confluent and highly viable (> 95%) when collected for injection.
  Note: If there is any question of tumor cell viability, test for viability by trypan blue staining or other method after tumor cell collection.
2. Resuspend cells in DPBS and centrifuge for 5 min at 300 x g. Repeat DPBS wash.
3. Count cells and confirm high viability (> 95%), then resuspend cells in DPBS at 3 x 10⁶ cells/ml.
4. Intravenously inject (in tail vein) 3 x 10⁵ Lewis lung carcinoma cells expressing red fluorescent protein (LLC-RFP) or other fluorescent-tagged tumor cell line resuspended in 100 μl of DPBS into the tail vein using a 30 gauge syringe.
Mouse imaging
1. Inject mouse intraperitoneally with an initial dose of 90 mg/kg ketamine hydrochloride and 15 mg/kg xylazine hydrochloride in 0.5 ml of PBS to anesthetize mouse. Maintain anesthesia during image acquisition with one-half dose subcutaneously boosting every 45 min for up to 3 h.
2. Placed mouse in the supine position on a heated microscope stage to achieve a rectal temperature of 37 °C.
3. Once adequate anesthesia is induced (tested by paw pinch), expose the trachea and separate from the surrounding connective tissue.
4. Cut a small opening in the anterior trachea parallel to the cartilaginous rings, and insert PE-90 tubing trimmed at a 45 degree angle into the trachea toward the lungs. Secure the tubing and close the skin around the trachea with Vetbond glue and connect to the mechanical ventilator. Apply a tidal volume of 8 to 10 μl/g body weight (room air or higher fractions of oxygen) with respiratory rates of approximately 120 breaths per min. This is the approximate normal breathing rate of an average size adult mouse (25-30 g).
5. Reassess depth of anesthesia with a paw pinch.
6. Dab mouse lightly with 70% ethanol around left rib cage and remove skin to expose ribs.
7. Gently insert scissors between the two lowest ribs and cut a 0.5 cm hole into the thoracic cavity.
8. Pull up second rib above hole with tweezers and then pipette approximately 300 μl of PBS into hole to help drop left lobe of the lung from the rib cage.
9. Continue applying upward pressure on the ribcage with tweezers in order to keep the lung away from the ribs and prevent lung damage while removing ribs. Carefully remove approximately 1.5 cm of the three anterior ribs overlying the left lung lobe as shown in Figure 1.
  
  Figure 1. Images of exposure of left lobe of lung as described in step B9
10. Apply a thin layer of high vacuum grease around the inner edge of the vacuum ring and then apply a 12-mm glass coverslip sealed with high vacuum grease to the vacuum suction ring. Apply 20 to 25 mmHg vacuum suction to the ring using a dedicated vacuum line attached to pressure gauge and regulator to adjust pressure.
11. Carefully lower thoracic suction window onto the flat surface of the left lung lobe, which will then enter the thoracic window and be stabilized for imaging as shown in Figure 2.
  
  Figure 2. Image of suction window on left lobe of the lung
12. Add ~200 μl DPBS to slideglass, engage microscope lens on imaging ring as shown in Figure 3, and acquire imaging as necessary. Confirm normal blood flow in lung by imaging to ensure that the ring has not caused vascular damage/blocking. Focusing on imaging an area that is fairly stabilized by the vacuum ring to prevent motion artifact and distortion of the images by pulsing of the lung. Representative lung imaging is shown in Video 1 and Video 2.
  
  Figure 3. Image of microscope lens on lung suction ring connected to lung of live mouse
13. After imaging turn off vacuum, remove microscope lens and imaging ring, and euthanize mouse.
  
  Video 1. Representative live imaging of Nur77-GFP high patrolling monocytes (Green), all CD45-APC⁺ immune cells (Blue), and LLC-RFP tumor (Red) in mouse lung. Nur77-GFP mice were IV injected with LLC-RFP tumor 24 h prior to imaging. CD45-APC was IV injected.
  
  Video 2. Representative three dimensional reconstruction of live imaging data using Imaris. Nur77-GFP^high patrolling monocytes (Green), GR1(Ly6G/C)-APC⁺ neutrophils and classical monocytes (Blue), and LLC-RFP tumor (Red) in mouse lung. Nur77-GFP mice were IV injected with LLC-RFP tumor 7 days prior to imaging. GR1(Ly6G/C)-APC was IV injected.

Data analysis

Three dimensional reconstructions and drift correction of lung images were performed using Imaris software (version 7.1.1 x 64). Detailed instructions on the use of Imaris software can be found at: http://www.bitplane.com/download/manuals/ReferenceManual6_1_0.pdf. Images were smoothed by median filtering at kernel size 3 x 3 pixels. When needed, motion artifacts caused by breathing were corrected with rigid body registration using an ImageJ plug-in (McArdle et al., 2014; McArdle et al., 2015). Imaris software was also used to automatically process 3D video data by detecting cells in each fluorescence channel, then creating tracks by linking the detected cells over time (using the Imaris 'Track spots over time' function). Tracks were manually edited to improve accuracy. Data for all experiments were analyzed with Prism software. Unpaired t-tests and two-way analysis of variance were used for comparison of experimental groups. P values of less than 0.05 were considered significant. The data appeared to be normally distributed with similar standard deviation and error observed between and within experimental groups.

Notes

Optional: Intravenously inject (retro-orbital) directly conjugated fluorescent antibodies (20 μg diluted to 100 μl in DPBS of either Ly6G: Neutrophils, CD3e: T Cells, CD31: endothelial cells, etc.) to label other immune cells or vasculature. Optimal color for antibody labeling will vary with microscope set-up but we find good imaging with APC/A647, FITC/A488, BV421 or PE labeling of antibodies. Antibodies should be injected just prior or during imaging. Good antibody labeling of cells can be detected in vivo for approximately 30 min to more than 3 h, and varies considerably depending on the antibody and fluorophore conjugate.
This same protocol and vacuum ring can be applied to image other organs (spleen, kidney, pancreas, skin, etc.). Ventilator is not necessary for imaging organs other than the lung.

Acknowledgments

This protocol is adapted from an earlier protocol describing live imaging of the lung (Thornton et al., 2012). This work was supported by NIH grants R01 HL118765 and R01 CA202987 (both to C.C.H.), American Heart Association Scientist Development Grant 125SDG12070005 (to R.N.H.), the La Jolla Institute for Allergy and Immunology Board of Directors Fellowship (to R.N.H.).

References

Hanna, R. N., Cekic, C., Sag, D., Tacke, R., Thomas, G. D., Nowyhed, H., Herrley, E., Rasquinha, N., McArdle, S., Wu, R., Peluso, E., Metzger, D., Ichinose, H., Shaked, I., Chodaczek, G., Biswas, S. K. and Hedrick, C. C. (2015). Patrolling monocytes control tumor metastasis to the lung. Science 350(6263): 985-990.
McArdle, S., Chodaczek, G., Ray, N. and Ley, K. (2015). Intravital live cell triggered imaging system reveals monocyte patrolling and macrophage migration in atherosclerotic arteries. J Biomed Opt 20(2): 26005.
McArdle, S., Acton, S. T., Ley, K. and Ray, N. (2014). Registering sequences of in vivo microscopy images for cell tracking using dynamic programming and minimum spanning trees. IEEE International Conference on Image Processing: 3547-3551.
Thornton, E. E., Krummel, M. F. and Looney, M. R. (2012). Live imaging of the lung. Curr Protoc Cytom Chapter 12: Unit12 28.